ST3GAL-1 expression was assessed by immunohistochemistry, and nomograms integrating ST3GAL-1 with other prognostic parameters were generated to refine individual risk stratification in ccRCC patients. Here, ST3GAL1 is linked to nonpapillary renal cell carcinoma.